TY - JOUR
KW - Analgesics, Opioid/adverse effects
KW - Buprenorphine/therapeutic use
KW - Drug Prescriptions
KW - Evidence-Based Medicine/methods
KW - Humans
KW - Methadone/therapeutic use
KW - Naltrexone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/drug therapy/epidemiology/etiology
KW - buprenorphine
KW - Methadone
KW - Naltrexone
KW - opioid epidemic
KW - opioid use disorder
KW - Prescribing
AU - J. L. Koehl
AU - D. E. Zimmerman
AU - P. J. Bridgeman
A1 - 
AD - Department of Pharmacy Practice, Massachusetts General Hospital, Boston, MA.; Department of Pharmacy Practice, Duquesne University, Pittsburgh, PA.; Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ.
BT - American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
C5 - Education & Workforce; Opioids & Substance Use
CP - 15
CY - England
DO - 10.1093/ajhp/zxz105
IS - 15
JF - American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
LA - eng
M1 - Journal Article
PP - England
PY - 2019
SN - 1535-2900; 1079-2082
SP - 1097
EP - 1103
EP - 
T1 - Medications for management of opioid use disorder
T2 - American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
TI - Medications for management of opioid use disorder
U1 - Education & Workforce; Opioids & Substance Use
U2 - 31361869
U3 - 10.1093/ajhp/zxz105
VL - 76
VO - 1535-2900; 1079-2082
Y1 - 2019
Y2 - Jul 18
ER -